, a new virus from the coronavirus strain has caused pneumonia in patients in Wuhan, China. The World Health Organization (WHO) named the virus COVID-19, which rapidly became pandemic. According to the WHO report on September 2, 2020, the total confirmed COVID-19 cases were 25,602,665, of whom 852,758 have died. Mortality from COVID-19 is higher than that from influenza A, severe acute respiratory syndrome-coronavirus (SARS-CoV), and Middle East respiratory syndrome (MERS) [1, 2]. Currently, no specific treatment or approved effective vaccine is available, so sanitation, social distancing, quarantine, and control of COVID-19 risk factors are the most effective way to control the disease [3, 4]. Both COVID-19 and obesity are pandemic [5] and study of obesity impact on COVID-19 disease could be an interesting topic. According to available data and clinical practice at the US Centers for Disease Control and Prevention [6], morbid obesity (body mass index or BMI ≥ 40 kg/m 2) is a risk factor for poor prognosis and higher mortality in patients with * Maryam Vasheghani